468 related articles for article (PubMed ID: 11522182)
1. HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells.
Chiao C; Bader T; Stenger JE; Baldwin W; Brady J; Barrett JC
AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1125-32. PubMed ID: 11522182
[TBL] [Abstract][Full Text] [Related]
2. Enhanced nuclear factor-kappa B activation induced by tumour necrosis factor-alpha in stably tat-transfected cells is associated with the presence of cell-surface-bound Tat protein.
Ramazzotti E; Vignoli M; Re MC; Furlini G; La Placa M
AIDS; 1996 May; 10(5):455-61. PubMed ID: 8724035
[TBL] [Abstract][Full Text] [Related]
3. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
Börset M; Medvedev AE; Sundan A; Espevik T
Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor induces lipopolysaccharide tolerance in a human adenocarcinoma cell line mainly through the TNF p55 receptor.
Laegreid A; Thommesen L; Jahr TG; Sundan A; Espevik T
J Biol Chem; 1995 Oct; 270(43):25418-25. PubMed ID: 7592709
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state.
Westendorp MO; Shatrov VA; Schulze-Osthoff K; Frank R; Kraft M; Los M; Krammer PH; Dröge W; Lehmann V
EMBO J; 1995 Feb; 14(3):546-54. PubMed ID: 7859743
[TBL] [Abstract][Full Text] [Related]
6. Iron chelation decreases human immunodeficiency virus-1 Tat potentiated tumor necrosis factor-induced NF-kappa B activation in Jurkat cells.
Shatrov VA; Boelaert JR; Chouaib S; Dröge W; Lehmann V
Eur Cytokine Netw; 1997 Mar; 8(1):37-43. PubMed ID: 9110146
[TBL] [Abstract][Full Text] [Related]
7. Down-modulation of cell surface expression of p80 form of the tumor necrosis factor receptor by human immunodeficiency virus-1 tat gene.
Pocsik E; Higuchi M; Aggarwal BB
Lymphokine Cytokine Res; 1992 Dec; 11(6):317-25. PubMed ID: 1335762
[TBL] [Abstract][Full Text] [Related]
8. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.
Kelly GD; Morris CB; Offermann MK
Virology; 1999 Oct; 263(1):128-38. PubMed ID: 10544088
[TBL] [Abstract][Full Text] [Related]
9. HIV type 1 glycoprotein 120 amplifies tumor necrosis factor-induced NF-kappa B activation in Jurkat cells.
Shatrov VA; Ratter F; Gruber A; Dröge W; Lehmann V
AIDS Res Hum Retroviruses; 1996 Sep; 12(13):1209-16. PubMed ID: 8870842
[TBL] [Abstract][Full Text] [Related]
10. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor receptor p55 mediates induction of HIV type 1 expression in chronically infected U1 cells.
Edfjäll C; Jacobsen H; Lötscher H; Mous J
AIDS Res Hum Retroviruses; 1996 Feb; 12(3):199-204. PubMed ID: 8835197
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase.
Peraldi P; Hotamisligil GS; Buurman WA; White MF; Spiegelman BM
J Biol Chem; 1996 May; 271(22):13018-22. PubMed ID: 8662983
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
Popik W; Pitha PM
Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities.
Medvedev AE; Sundan A; Espevik T
Eur J Immunol; 1994 Nov; 24(11):2842-9. PubMed ID: 7957575
[TBL] [Abstract][Full Text] [Related]
15. TNF-alpha-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation.
Hu X; Tang M; Fisher AB; Olashaw N; Zuckerman KS
J Immunol; 1999 Sep; 163(6):3106-15. PubMed ID: 10477576
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional up-regulation of interleukin 4 receptors by human immunodeficiency virus type 1 tat gene.
Husain SR; Leland P; Aggarwal BB; Puri RK
AIDS Res Hum Retroviruses; 1996 Sep; 12(14):1349-59. PubMed ID: 8891114
[TBL] [Abstract][Full Text] [Related]
17. Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells.
Amrani Y; Panettieri RA; Frossard N; Bronner C
Am J Respir Cell Mol Biol; 1996 Jul; 15(1):55-63. PubMed ID: 8679222
[TBL] [Abstract][Full Text] [Related]
18. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys.
Brother MB; Chang HK; Lisziewicz J; Su D; Murty LC; Ensoli B
Virology; 1996 Aug; 222(1):252-6. PubMed ID: 8806505
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
